8-144356205-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_012162.4(FBXL6):āc.1235A>Gā(p.Gln412Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000383 in 1,305,106 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_012162.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FBXL6 | NM_012162.4 | c.1235A>G | p.Gln412Arg | missense_variant | 8/9 | ENST00000331890.6 | |
FBXL6 | NM_024555.6 | c.1217A>G | p.Gln406Arg | missense_variant | 8/9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FBXL6 | ENST00000331890.6 | c.1235A>G | p.Gln412Arg | missense_variant | 8/9 | 1 | NM_012162.4 | P2 |
Frequencies
GnomAD3 genomes AF: 0.0000433 AC: 3AN: 69302Hom.: 0 Cov.: 20
GnomAD4 exome AF: 0.00000162 AC: 2AN: 1235804Hom.: 0 Cov.: 35 AF XY: 0.00000164 AC XY: 1AN XY: 611234
GnomAD4 genome AF: 0.0000433 AC: 3AN: 69302Hom.: 0 Cov.: 20 AF XY: 0.0000594 AC XY: 2AN XY: 33698
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 19, 2022 | The c.1235A>G (p.Q412R) alteration is located in exon 8 (coding exon 8) of the FBXL6 gene. This alteration results from a A to G substitution at nucleotide position 1235, causing the glutamine (Q) at amino acid position 412 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at